We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 659

Recent releases on systemic risk: GSIBs and GECC
  • Kaye Scholer LLP
  • USA
  • July 29 2015

On July 20, 2015, the Federal Reserve Board adopted a final rule (GSIB Rule) regarding capital surcharges applicable to US global systemically


And now a word from the panel: the rocket docket!
  • Kaye Scholer LLP
  • USA
  • July 28 2015

Welcome to the latest edition of "And Now a Word from the Panel," Multidistrict a column which "rides the circuit" with the Judicial Panel on


Wearable gizmos vs. medical devices: how companies can comply with FDA security recommendations
  • Kaye Scholer LLP
  • USA
  • July 16 2015

Kaye Scholer Counsel Helen Christakos, whose practice areas include intellectual property, technology and data security, discusses the U.S. Food and


Conflicts under the microscopeSEC charges and settles with KKR
  • Kaye Scholer LLP
  • USA
  • July 14 2015

The recent agreement by Kohlberg Kravis Roberts & Co. LP (KKR) to pay almost $30 million to settle charges with the US Securities and Exchange


Is broadest reasonable interpretation here to stay?
  • Kaye Scholer LLP
  • USA
  • July 9 2015

Claim construction is just about the most important part of a patent lawsuit. And when it comes to a prior art invalidity challenge, the standard


Court concludes that “Hobson’s choice” in debt restructuring violates TIA Section 316(b)
  • Kaye Scholer LLP
  • USA
  • July 8 2015

On April 8, 2015, we distributed a Corporate Alert outlining two important decisions of the US District Court for the Southern District of New York


SEC issues Dodd-Frank compensation clawback proposal
  • Kaye Scholer LLP
  • USA
  • July 7 2015

On July 1, 2015, the SEC proposed a new rule, and rule and form amendments (the Proposal), to implement the provisions of Section 954 of the


Timing and considerations for filing an opposition at TTAB
  • Kaye Scholer LLP
  • USA
  • July 6 2015

An opposition proceeding affords third parties an opportunity to object to a trademark application that they believe may harm their business or cause


Third Circuit’s King Drug decision holds no-AG provision can constitute actionable payment
  • Kaye Scholer LLP
  • USA
  • June 30 2015

In the first appellate court decision to consider the issue since FTC v. Actavis, 133 S. Ct. 2223 (2013), the Third Circuit recently held that


Beware increased privacy and data security scrutiny in M&A
  • Kaye Scholer LLP
  • USA
  • June 16 2015

It is important to examine privacy and data security issues in the context of merger and acquisition regulations. M&A agreements frequently contain